KIF5A and hereditary spastic paraplegia: KIF5A variants have also been implicated in neurodegenerative diseases such as CMT2, HSP, and ALS (Brenner et al., 2018; Citrigno et al., 2018; Filosto et al., 2018; Nam et al., 2018).